ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical OEM and ODM Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-30I15404
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical OEM and ODM Market Research Report 2023
BUY CHAPTERS

Global Pharmaceutical OEM and ODM Market Research Report 2025

Code: QYRE-Auto-30I15404
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CD Formulation
Synmosa
Dr. Japan Co., Ltd
JPS Pharmaceutical
New-In CO., Ltd.
DENKEN GROUP
PIM Pharmaceuticals
IL Myeong Pharmaceutical Co., Ltd.
Itoh Kanpo Pharmaceutical Co., Ltd.
Hanso Pharmaceutical
Guangdong Qingyunshan Pharmaceutical Co.,Ltd.
Weidar Chemical & Pharmaceutical Co., Ltd.
Tianjin Hezhi Pharmaceutical Group Co., Ltd.
Kosei Pharmaceutical Co., Ltd.
Kolmar Korea

Pharmaceutical OEM and ODM Market

The global market for Pharmaceutical OEM and ODM was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Pharmaceutical OEM and ODM is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical OEM and ODM is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pharmaceutical OEM and ODM in Traditional Chinese Medicine is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pharmaceutical OEM and ODM include JPS Pharmaceutical, New-In CO., Ltd., Kosei Pharmaceutical Co., Ltd., CD Formulation, DENKEN GROUP, PIM Pharmaceuticals, IL Myeong Pharmaceutical Co., Ltd., Kolmar Korea, Synmosa, Itoh Kanpo Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical OEM and ODM, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical OEM and ODM.
The Pharmaceutical OEM and ODM market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical OEM and ODM market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical OEM and ODM companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical OEM and ODM Market Report

Report Metric Details
Report Name Pharmaceutical OEM and ODM Market
Segment by Type
  • Pharmaceutical OEM
  • Pharmaceutical ODM
Segment by Application
  • Traditional Chinese Medicine
  • Western Medicine
  • Biologics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company JPS Pharmaceutical, New-In CO., Ltd., Kosei Pharmaceutical Co., Ltd., CD Formulation, DENKEN GROUP, PIM Pharmaceuticals, IL Myeong Pharmaceutical Co., Ltd., Kolmar Korea, Synmosa, Itoh Kanpo Pharmaceutical Co., Ltd., Hanso Pharmaceutical, Dr.Japan Co., Ltd., Guangdong Qingyunshan Pharmaceutical Co.,Ltd., Weidar Chemical & Pharmaceutical Co., Ltd., Tianjin Hezhi Pharmaceutical Group Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical OEM and ODM company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical OEM and ODM Market report?

Ans: The main players in the Pharmaceutical OEM and ODM Market are JPS Pharmaceutical, New-In CO., Ltd., Kosei Pharmaceutical Co., Ltd., CD Formulation, DENKEN GROUP, PIM Pharmaceuticals, IL Myeong Pharmaceutical Co., Ltd., Kolmar Korea, Synmosa, Itoh Kanpo Pharmaceutical Co., Ltd., Hanso Pharmaceutical, Dr.Japan Co., Ltd., Guangdong Qingyunshan Pharmaceutical Co.,Ltd., Weidar Chemical & Pharmaceutical Co., Ltd., Tianjin Hezhi Pharmaceutical Group Co., Ltd.

What are the Application segmentation covered in the Pharmaceutical OEM and ODM Market report?

Ans: The Applications covered in the Pharmaceutical OEM and ODM Market report are Traditional Chinese Medicine, Western Medicine, Biologics, Others

What are the Type segmentation covered in the Pharmaceutical OEM and ODM Market report?

Ans: The Types covered in the Pharmaceutical OEM and ODM Market report are Pharmaceutical OEM, Pharmaceutical ODM

Recommended Reports

Pharmaceutical Services

Pain Relief & Medications

Traditional & Herbal Medicine

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical OEM and ODM Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pharmaceutical OEM
1.2.3 Pharmaceutical ODM
1.3 Market by Application
1.3.1 Global Pharmaceutical OEM and ODM Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Traditional Chinese Medicine
1.3.3 Western Medicine
1.3.4 Biologics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical OEM and ODM Market Perspective (2020-2031)
2.2 Global Pharmaceutical OEM and ODM Growth Trends by Region
2.2.1 Global Pharmaceutical OEM and ODM Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical OEM and ODM Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical OEM and ODM Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical OEM and ODM Market Dynamics
2.3.1 Pharmaceutical OEM and ODM Industry Trends
2.3.2 Pharmaceutical OEM and ODM Market Drivers
2.3.3 Pharmaceutical OEM and ODM Market Challenges
2.3.4 Pharmaceutical OEM and ODM Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical OEM and ODM Players by Revenue
3.1.1 Global Top Pharmaceutical OEM and ODM Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical OEM and ODM Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical OEM and ODM Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical OEM and ODM Revenue
3.4 Global Pharmaceutical OEM and ODM Market Concentration Ratio
3.4.1 Global Pharmaceutical OEM and ODM Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical OEM and ODM Revenue in 2024
3.5 Global Key Players of Pharmaceutical OEM and ODM Head office and Area Served
3.6 Global Key Players of Pharmaceutical OEM and ODM, Product and Application
3.7 Global Key Players of Pharmaceutical OEM and ODM, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical OEM and ODM Breakdown Data by Type
4.1 Global Pharmaceutical OEM and ODM Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical OEM and ODM Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical OEM and ODM Breakdown Data by Application
5.1 Global Pharmaceutical OEM and ODM Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical OEM and ODM Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical OEM and ODM Market Size (2020-2031)
6.2 North America Pharmaceutical OEM and ODM Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical OEM and ODM Market Size by Country (2020-2025)
6.4 North America Pharmaceutical OEM and ODM Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical OEM and ODM Market Size (2020-2031)
7.2 Europe Pharmaceutical OEM and ODM Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical OEM and ODM Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical OEM and ODM Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical OEM and ODM Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical OEM and ODM Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical OEM and ODM Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical OEM and ODM Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical OEM and ODM Market Size (2020-2031)
9.2 Latin America Pharmaceutical OEM and ODM Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical OEM and ODM Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical OEM and ODM Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical OEM and ODM Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical OEM and ODM Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical OEM and ODM Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical OEM and ODM Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 JPS Pharmaceutical
11.1.1 JPS Pharmaceutical Company Details
11.1.2 JPS Pharmaceutical Business Overview
11.1.3 JPS Pharmaceutical Pharmaceutical OEM and ODM Introduction
11.1.4 JPS Pharmaceutical Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.1.5 JPS Pharmaceutical Recent Development
11.2 New-In CO., Ltd.
11.2.1 New-In CO., Ltd. Company Details
11.2.2 New-In CO., Ltd. Business Overview
11.2.3 New-In CO., Ltd. Pharmaceutical OEM and ODM Introduction
11.2.4 New-In CO., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.2.5 New-In CO., Ltd. Recent Development
11.3 Kosei Pharmaceutical Co., Ltd.
11.3.1 Kosei Pharmaceutical Co., Ltd. Company Details
11.3.2 Kosei Pharmaceutical Co., Ltd. Business Overview
11.3.3 Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Introduction
11.3.4 Kosei Pharmaceutical Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.3.5 Kosei Pharmaceutical Co., Ltd. Recent Development
11.4 CD Formulation
11.4.1 CD Formulation Company Details
11.4.2 CD Formulation Business Overview
11.4.3 CD Formulation Pharmaceutical OEM and ODM Introduction
11.4.4 CD Formulation Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.4.5 CD Formulation Recent Development
11.5 DENKEN GROUP
11.5.1 DENKEN GROUP Company Details
11.5.2 DENKEN GROUP Business Overview
11.5.3 DENKEN GROUP Pharmaceutical OEM and ODM Introduction
11.5.4 DENKEN GROUP Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.5.5 DENKEN GROUP Recent Development
11.6 PIM Pharmaceuticals
11.6.1 PIM Pharmaceuticals Company Details
11.6.2 PIM Pharmaceuticals Business Overview
11.6.3 PIM Pharmaceuticals Pharmaceutical OEM and ODM Introduction
11.6.4 PIM Pharmaceuticals Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.6.5 PIM Pharmaceuticals Recent Development
11.7 IL Myeong Pharmaceutical Co., Ltd.
11.7.1 IL Myeong Pharmaceutical Co., Ltd. Company Details
11.7.2 IL Myeong Pharmaceutical Co., Ltd. Business Overview
11.7.3 IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Introduction
11.7.4 IL Myeong Pharmaceutical Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.7.5 IL Myeong Pharmaceutical Co., Ltd. Recent Development
11.8 Kolmar Korea
11.8.1 Kolmar Korea Company Details
11.8.2 Kolmar Korea Business Overview
11.8.3 Kolmar Korea Pharmaceutical OEM and ODM Introduction
11.8.4 Kolmar Korea Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.8.5 Kolmar Korea Recent Development
11.9 Synmosa
11.9.1 Synmosa Company Details
11.9.2 Synmosa Business Overview
11.9.3 Synmosa Pharmaceutical OEM and ODM Introduction
11.9.4 Synmosa Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.9.5 Synmosa Recent Development
11.10 Itoh Kanpo Pharmaceutical Co., Ltd.
11.10.1 Itoh Kanpo Pharmaceutical Co., Ltd. Company Details
11.10.2 Itoh Kanpo Pharmaceutical Co., Ltd. Business Overview
11.10.3 Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Introduction
11.10.4 Itoh Kanpo Pharmaceutical Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.10.5 Itoh Kanpo Pharmaceutical Co., Ltd. Recent Development
11.11 Hanso Pharmaceutical
11.11.1 Hanso Pharmaceutical Company Details
11.11.2 Hanso Pharmaceutical Business Overview
11.11.3 Hanso Pharmaceutical Pharmaceutical OEM and ODM Introduction
11.11.4 Hanso Pharmaceutical Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.11.5 Hanso Pharmaceutical Recent Development
11.12 Dr.Japan Co., Ltd.
11.12.1 Dr.Japan Co., Ltd. Company Details
11.12.2 Dr.Japan Co., Ltd. Business Overview
11.12.3 Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Introduction
11.12.4 Dr.Japan Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.12.5 Dr.Japan Co., Ltd. Recent Development
11.13 Guangdong Qingyunshan Pharmaceutical Co.,Ltd.
11.13.1 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Company Details
11.13.2 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Business Overview
11.13.3 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Introduction
11.13.4 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.13.5 Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Recent Development
11.14 Weidar Chemical & Pharmaceutical Co., Ltd.
11.14.1 Weidar Chemical & Pharmaceutical Co., Ltd. Company Details
11.14.2 Weidar Chemical & Pharmaceutical Co., Ltd. Business Overview
11.14.3 Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Introduction
11.14.4 Weidar Chemical & Pharmaceutical Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.14.5 Weidar Chemical & Pharmaceutical Co., Ltd. Recent Development
11.15 Tianjin Hezhi Pharmaceutical Group Co., Ltd.
11.15.1 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Company Details
11.15.2 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Business Overview
11.15.3 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Introduction
11.15.4 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025)
11.15.5 Tianjin Hezhi Pharmaceutical Group Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
CD Formulation
Synmosa
Dr. Japan Co., Ltd
JPS Pharmaceutical
New-In CO., Ltd.
DENKEN GROUP
PIM Pharmaceuticals
IL Myeong Pharmaceutical Co., Ltd.
Itoh Kanpo Pharmaceutical Co., Ltd.
Hanso Pharmaceutical
Guangdong Qingyunshan Pharmaceutical Co.,Ltd.
Weidar Chemical & Pharmaceutical Co., Ltd.
Tianjin Hezhi Pharmaceutical Group Co., Ltd.
Kosei Pharmaceutical Co., Ltd.
Kolmar Korea
List of Tables
 Table 1. Global Pharmaceutical OEM and ODM Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Pharmaceutical OEM
 Table 3. Key Players of Pharmaceutical ODM
 Table 4. Global Pharmaceutical OEM and ODM Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharmaceutical OEM and ODM Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmaceutical OEM and ODM Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharmaceutical OEM and ODM Market Share by Region (2020-2025)
 Table 8. Global Pharmaceutical OEM and ODM Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharmaceutical OEM and ODM Market Share by Region (2026-2031)
 Table 10. Pharmaceutical OEM and ODM Market Trends
 Table 11. Pharmaceutical OEM and ODM Market Drivers
 Table 12. Pharmaceutical OEM and ODM Market Challenges
 Table 13. Pharmaceutical OEM and ODM Market Restraints
 Table 14. Global Pharmaceutical OEM and ODM Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharmaceutical OEM and ODM Market Share by Players (2020-2025)
 Table 16. Global Top Pharmaceutical OEM and ODM Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical OEM and ODM as of 2024)
 Table 17. Ranking of Global Top Pharmaceutical OEM and ODM Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharmaceutical OEM and ODM Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharmaceutical OEM and ODM, Headquarters and Area Served
 Table 20. Global Key Players of Pharmaceutical OEM and ODM, Product and Application
 Table 21. Global Key Players of Pharmaceutical OEM and ODM, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharmaceutical OEM and ODM Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharmaceutical OEM and ODM Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharmaceutical OEM and ODM Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmaceutical OEM and ODM Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharmaceutical OEM and ODM Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharmaceutical OEM and ODM Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharmaceutical OEM and ODM Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharmaceutical OEM and ODM Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharmaceutical OEM and ODM Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharmaceutical OEM and ODM Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharmaceutical OEM and ODM Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharmaceutical OEM and ODM Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharmaceutical OEM and ODM Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharmaceutical OEM and ODM Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharmaceutical OEM and ODM Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharmaceutical OEM and ODM Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharmaceutical OEM and ODM Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmaceutical OEM and ODM Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharmaceutical OEM and ODM Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharmaceutical OEM and ODM Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharmaceutical OEM and ODM Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharmaceutical OEM and ODM Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharmaceutical OEM and ODM Market Size by Country (2026-2031) & (US$ Million)
 Table 46. JPS Pharmaceutical Company Details
 Table 47. JPS Pharmaceutical Business Overview
 Table 48. JPS Pharmaceutical Pharmaceutical OEM and ODM Product
 Table 49. JPS Pharmaceutical Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 50. JPS Pharmaceutical Recent Development
 Table 51. New-In CO., Ltd. Company Details
 Table 52. New-In CO., Ltd. Business Overview
 Table 53. New-In CO., Ltd. Pharmaceutical OEM and ODM Product
 Table 54. New-In CO., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 55. New-In CO., Ltd. Recent Development
 Table 56. Kosei Pharmaceutical Co., Ltd. Company Details
 Table 57. Kosei Pharmaceutical Co., Ltd. Business Overview
 Table 58. Kosei Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product
 Table 59. Kosei Pharmaceutical Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 60. Kosei Pharmaceutical Co., Ltd. Recent Development
 Table 61. CD Formulation Company Details
 Table 62. CD Formulation Business Overview
 Table 63. CD Formulation Pharmaceutical OEM and ODM Product
 Table 64. CD Formulation Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 65. CD Formulation Recent Development
 Table 66. DENKEN GROUP Company Details
 Table 67. DENKEN GROUP Business Overview
 Table 68. DENKEN GROUP Pharmaceutical OEM and ODM Product
 Table 69. DENKEN GROUP Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 70. DENKEN GROUP Recent Development
 Table 71. PIM Pharmaceuticals Company Details
 Table 72. PIM Pharmaceuticals Business Overview
 Table 73. PIM Pharmaceuticals Pharmaceutical OEM and ODM Product
 Table 74. PIM Pharmaceuticals Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 75. PIM Pharmaceuticals Recent Development
 Table 76. IL Myeong Pharmaceutical Co., Ltd. Company Details
 Table 77. IL Myeong Pharmaceutical Co., Ltd. Business Overview
 Table 78. IL Myeong Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product
 Table 79. IL Myeong Pharmaceutical Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 80. IL Myeong Pharmaceutical Co., Ltd. Recent Development
 Table 81. Kolmar Korea Company Details
 Table 82. Kolmar Korea Business Overview
 Table 83. Kolmar Korea Pharmaceutical OEM and ODM Product
 Table 84. Kolmar Korea Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 85. Kolmar Korea Recent Development
 Table 86. Synmosa Company Details
 Table 87. Synmosa Business Overview
 Table 88. Synmosa Pharmaceutical OEM and ODM Product
 Table 89. Synmosa Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 90. Synmosa Recent Development
 Table 91. Itoh Kanpo Pharmaceutical Co., Ltd. Company Details
 Table 92. Itoh Kanpo Pharmaceutical Co., Ltd. Business Overview
 Table 93. Itoh Kanpo Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product
 Table 94. Itoh Kanpo Pharmaceutical Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 95. Itoh Kanpo Pharmaceutical Co., Ltd. Recent Development
 Table 96. Hanso Pharmaceutical Company Details
 Table 97. Hanso Pharmaceutical Business Overview
 Table 98. Hanso Pharmaceutical Pharmaceutical OEM and ODM Product
 Table 99. Hanso Pharmaceutical Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 100. Hanso Pharmaceutical Recent Development
 Table 101. Dr.Japan Co., Ltd. Company Details
 Table 102. Dr.Japan Co., Ltd. Business Overview
 Table 103. Dr.Japan Co., Ltd. Pharmaceutical OEM and ODM Product
 Table 104. Dr.Japan Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 105. Dr.Japan Co., Ltd. Recent Development
 Table 106. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Company Details
 Table 107. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Business Overview
 Table 108. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Pharmaceutical OEM and ODM Product
 Table 109. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 110. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Recent Development
 Table 111. Weidar Chemical & Pharmaceutical Co., Ltd. Company Details
 Table 112. Weidar Chemical & Pharmaceutical Co., Ltd. Business Overview
 Table 113. Weidar Chemical & Pharmaceutical Co., Ltd. Pharmaceutical OEM and ODM Product
 Table 114. Weidar Chemical & Pharmaceutical Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 115. Weidar Chemical & Pharmaceutical Co., Ltd. Recent Development
 Table 116. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Company Details
 Table 117. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Business Overview
 Table 118. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Pharmaceutical OEM and ODM Product
 Table 119. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Revenue in Pharmaceutical OEM and ODM Business (2020-2025) & (US$ Million)
 Table 120. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical OEM and ODM Picture
 Figure 2. Global Pharmaceutical OEM and ODM Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical OEM and ODM Market Share by Type: 2024 VS 2031
 Figure 4. Pharmaceutical OEM Features
 Figure 5. Pharmaceutical ODM Features
 Figure 6. Global Pharmaceutical OEM and ODM Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmaceutical OEM and ODM Market Share by Application: 2024 VS 2031
 Figure 8. Traditional Chinese Medicine Case Studies
 Figure 9. Western Medicine Case Studies
 Figure 10. Biologics Case Studies
 Figure 11. Others Case Studies
 Figure 12. Pharmaceutical OEM and ODM Report Years Considered
 Figure 13. Global Pharmaceutical OEM and ODM Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pharmaceutical OEM and ODM Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pharmaceutical OEM and ODM Market Share by Region: 2024 VS 2031
 Figure 16. Global Pharmaceutical OEM and ODM Market Share by Players in 2024
 Figure 17. Global Top Pharmaceutical OEM and ODM Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical OEM and ODM as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical OEM and ODM Revenue in 2024
 Figure 19. North America Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pharmaceutical OEM and ODM Market Share by Country (2020-2031)
 Figure 21. United States Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmaceutical OEM and ODM Market Share by Country (2020-2031)
 Figure 25. Germany Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pharmaceutical OEM and ODM Market Share by Region (2020-2031)
 Figure 33. China Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmaceutical OEM and ODM Market Share by Country (2020-2031)
 Figure 41. Mexico Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pharmaceutical OEM and ODM Market Share by Country (2020-2031)
 Figure 45. Turkey Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pharmaceutical OEM and ODM Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. JPS Pharmaceutical Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 49. New-In CO., Ltd. Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 50. Kosei Pharmaceutical Co., Ltd. Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 51. CD Formulation Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 52. DENKEN GROUP Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 53. PIM Pharmaceuticals Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 54. IL Myeong Pharmaceutical Co., Ltd. Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 55. Kolmar Korea Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 56. Synmosa Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 57. Itoh Kanpo Pharmaceutical Co., Ltd. Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 58. Hanso Pharmaceutical Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 59. Dr.Japan Co., Ltd. Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 60. Guangdong Qingyunshan Pharmaceutical Co.,Ltd. Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 61. Weidar Chemical & Pharmaceutical Co., Ltd. Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 62. Tianjin Hezhi Pharmaceutical Group Co., Ltd. Revenue Growth Rate in Pharmaceutical OEM and ODM Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Diaper OEM and ODM Market Research Report 2024
Global Home appliance OEM and ODM Market Research Report 2024
Global Pharmaceutical Products and CMO Market Research Report 2024
TV OEM ODM Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Food Supplement OEM and ODM Market Research Report 2024
Global Laptop OEM ODM Market Research Report 2024
Global Baby Diaper OEM and ODM Market Research Report 2024
Global Automotive OEM Key Market Research Report 2024
Global Pharmaceutical Paper Market Research Report 2024
Global Electric Two Wheeler OEM and ODM Market Research Report 2025
Global Pharmaceutical ERP Market Research Report 2024
Pharmaceutical Product Information Management System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Printing Ink Market Research Report 2025
Global Laptop and Tablet OEM ODM Market Research Report 2024
Global Medical Devices OEM Market Research Report 2024
Global Collagen Drink OEM and ODM Market Research Report 2024
Global Refrigerator OEM and ODM Market Research Report 2024
Global Pharmaceutical Labeling Market Research Report 2024
Global Knowledge Management in Pharmaceutical Market Research Report 2024
Pharmaceutical CRDMO Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions